Introgen Therapeutics, Inc. (INGN) Earnings
|
Expand Research on INGN
| Next EPS Date | 5/7/24 | EPS Growth Rate | +13.6% |
|---|---|---|---|
| Average EPS % Beat Rate | -95.0% | Revenue Growth Rate | +2.0% |
| Average % Move 1-Wk after EPS | -15.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/24  |
Q124 | N/A | -$0.76 | N/A | N/A | $73.68M | = | N/A | N/A | ||
| 2/27/24 | Q423 | -$1.14 | -$0.63 | -$0.51 | $75.9M | $77M | = |  | | Details | |
| 11/7/23 | Q323 | -$1.97 | -$0.49 | -$1.48 | $84M | $82.09M | N/A | | | Details | |
| 8/7/23 | Q223 | -$0.42 | -$0.59 | +$0.17 | $83.6M | $92.2M | N/A | | | Details | |
| 5/4/23 | Q123 | -$0.88 | -$0.70 | -$0.18 | $72.2M | $76.31M | N/A | | | Details | |
| 2/23/23 | Q422 | -$0.57 | -$0.57 | $0.00 | $88.09M | $89.49M | N/A | | | Details | |
| 11/2/22 | Q322 | $0.53 | -$0.30 | +$0.83 | $93.11M | $98.76M | N/A | | | Details | |
| 8/4/22 | Q222 | $0.22 | -$0.37 | +$0.59 | $101.56M | $100.64M | N/A | | | Details |
